EUVIMEDEUVIMED entdecken
Crossref

Rational design of dosage compensated expression vectors for multi‐subunit biologics manufacturing

Satish Kallappagoudar iD, Sultan Yilmaz, Xiangfeng Niu, Qinghao Zhang, Fernanda Sobreira iD, Xiaoyan Tang iD, Johan Jeong, Tania Chakraborty iD, Gabriele Vincelli, Shengyuan Zhao iD, Jeanne Baker, Laurence Fayadat-Dilman und 3 weitere

Biotechnology Progress · 03.11.2026

DOI: 10.1002/btpr.88566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Progress, online erschienen am 03.11.2026. Verfasst von Satish Kallappagoudar und 14 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Process Research and Development, MRL, Merck & Co., Inc., Rahway, New Jersey, USA. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chinese hamster ovary (CHO) cells are the predominant platform for biologics production. Expression of multi‐subunit proteins within a single CHO cell requires balanced subunit expression to achieve optimal product quality and yield. Through systematic analysis of CHO expression data generated at the discovery stage using co‐transfected monocistronic vectors, we found that subunit expression balance strongly correlates with product purity across both monoclonal and bispecific antibodies. These insights enabled the rational design of multicistronic vectors for production cell line development. For bispecific antibodies containing Fab and single‐chain variable fragment (scFv) arms, scFv chains were frequently overexpressed, contributing to reduced product purity. Increasing heavy chain (HC) expression, for example through the introduction of an additional HC gene copy, improved both purity and titer across multiple programs. Likewise, optimizing the relative positioning of knob and hole HC genes within bicistronic vectors helped balance chain expression and enhance product purity in a complex IgG‐like molecule. Overall, early‐stage monocistronic expression analysis provides a framework for rational vector design of multi‐subunit biologics, enabling more efficient cell line development with the potential to accelerate preclinical timelines and reduce resource utilization.

Schlagwörter

Stichwörter der Autor:innen

Chinese hamster ovary cellbispecific antibodiesdosage compensationexpression vector designmulticistronic vectorsmulti‐subunit biologics

Autor:innen und Institutionen

  • Biologics Process Research and Development, MRL, Merck & Co., Inc., Rahway, New Jersey, USA.
  • Discovery Biologics Protein Sciences, MRL, Merck & Co., Inc., South San Francisco, California, USA.
  • Discovery Analytical Research, MRL, Merck & Co., Inc., South San Francisco, California, USA.

ORCID-Profile: Satish Kallappagoudar, Fernanda Sobreira, Xiaoyan Tang, Tania Chakraborty, Shengyuan Zhao, Ren Liu

Zitieren

APA

Kallappagoudar, S., Yilmaz, S., Niu, X., Zhang, Q., Sobreira, F., Tang, X., Jeong, J., Chakraborty, T., Vincelli, G., Zhao, S., Baker, J., Fayadat-Dilman, L., Zhang, L., Hohn, M. J., & Liu, R. (2026). Rational design of dosage compensated expression vectors for multi‐subunit biologics manufacturing. Biotechnology Progress. https://doi.org/10.1002/btpr.88566

Vancouver

Kallappagoudar S, Yilmaz S, Niu X, Zhang Q, Sobreira F, Tang X, et al. Rational design of dosage compensated expression vectors for multi‐subunit biologics manufacturing. Biotechnology Progress. 2026. doi:10.1002/btpr.88566

BibTeX
@article{Kallappagoudar2026,
  author = {Kallappagoudar, Satish and Yilmaz, Sultan and Niu, Xiangfeng and Zhang, Qinghao and Sobreira, Fernanda and Tang, Xiaoyan and Jeong, Johan and Chakraborty, Tania and Vincelli, Gabriele and Zhao, Shengyuan and Baker, Jeanne and Fayadat-Dilman, Laurence and Zhang, Lin and Hohn, Michael Jurgen and Liu, Ren},
  title = {Rational design of dosage compensated expression vectors for multi‐subunit biologics manufacturing},
  journal = {Biotechnology Progress},
  year = {2026},
  doi = {10.1002/btpr.88566}
}
Kostenlos starten →